On 2024-02-27, Recursion Pharmaceuticals, Inc. (RXRX) announced earnings per share of $-0.40 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.46.
The next expected annoucement date for quarterly earnings is 2024-05-09, with an average estimated earnings per share of $-0.43 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-02-27 | 2023-12-31 | $-0.46 | $-0.40 |
| 2023-11-09 | 2023-09-30 | $-0.38 | $-0.43 |
| 2023-08-08 | 2023-06-30 | $-0.38 | $-0.38 |
| 2023-05-08 | 2023-03-31 | $-0.34 | $-0.34 |
| 2023-02-27 | 2022-12-31 | $-0.15 | $-0.31 |
| 2022-11-08 | 2022-09-30 | $-0.36 | $-0.35 |
| 2022-08-09 | 2022-06-30 | $-0.35 | $-0.38 |
| 2022-05-10 | 2022-03-31 | $0.51 | $-0.33 |
| 2022-03-23 | 2021-12-31 | $-0.30 | $-0.38 |
| 2021-11-10 | 2021-09-30 | $-0.28 | $-0.28 |
| 2021-08-13 | 2021-06-30 | $-0.23 | $-0.31 |
| 2021-05-12 | 2021-03-31 | -- | $-1.33 |